Skip to main content

Advertisement

Log in

Doxycycline-Mediated Protective Effect Against Focal Cerebral Ischemia–Reperfusion Injury Through the Modulation of Tight Junctions and PKCδ Signaling in Rats

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The strategy for the development of effective and safe neuroprotective agents has great potential to reduce cerebral ischemia–reperfusion injury and improve the functional outcome in stroke patients. Recently, doxycycline, a tetracycline antibiotic, has been shown to have neuroprotective efficiency in reduction of a variety of ischemia–reperfusion injuries as well as ischemic brain damage. We used the rat models of middle cerebral artery occlusion (MCAO) and reperfusion to investigate the effects of treatments with doxycycline against the blood-brain barrier (BBB) leakage at 3, 12, 72, and 120 h of reperfusion. Male Sprague–Dawley rats were subjected to MCAO for 2 h followed by reperfusion for 3, 12, 72, and 120 h and received either doxycycline (45 mg/kg) or saline. The results showed that the treatment of doxycycline significantly reduced the BBB leakage and cerebral infarct volume, which were proved by Evans blue assay and TTC staining. Real-time PCR, immunohistochemistry, and western blot assay verified that the administration of doxycycline significantly up-regulated the expression of tight junction claudin-5, occludin, and ZO-1 from 3 to 120 h after reperfusion. The results of real-time PCR, western blot, and gelatin zymography analyses revealed that the gene and protein expression and activities of matrix metalloproteinases (MMPs) MMP-2 and MMP-9 were significantly elevated in a different time-dependent manner after ischemia–reperfusion but significantly inhibited by doxycycline treatment. Moreover, doxycycline could also significantly down-regulate the expression of PKCδ mRNA and protein after ischemia–reperfusion. These results suggested that the protective effects of doxycycline against BBB damage induced by reperfusion might be related to the up-regulation of tight junction proteins and inhibition of MMP-2, MMP-9, and PKCδ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Angelow S, Zeni P, Höhn B, Galla HJ (2005) Phorbol ester induced short-and long-term permeabilization of the blood–CSF barrier in vitro. Brain Res 1063:168–179

    Article  PubMed  CAS  Google Scholar 

  • Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 6:1–13

    Article  Google Scholar 

  • Bauer AT, Bürgers HF, Rabie T, Marti HH (2010) Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 30:837–848

    Article  PubMed  CAS  Google Scholar 

  • Bazzoni G, Dejana E (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84:869–901

    Article  PubMed  CAS  Google Scholar 

  • Biegel D, Spencer DD, Pachter JS (1995) Isolation and culture of human brain microvessel endothelial cells for the study of blood-brain barrier properties in vitro. Brain Res 692:183–189

    Article  PubMed  CAS  Google Scholar 

  • Bright R, Mochly-Rosen D (2005) The role of protein kinase C in cerebral ischemic and reperfusion Injury. Stroke 36:2781–2790

    Article  PubMed  CAS  Google Scholar 

  • Bright R, Raval AP, Dembner JM, Pérez-Pinzón MA, Steinberg GK, Yenari MA, Mochly-Rosen D (2004) Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci 24:6880–6888

    Article  PubMed  CAS  Google Scholar 

  • Castro MM, Kandasamy AD, Youssef N, Schulz R (2011) Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases. Pharmacol Res. May 31. [Epub ahead of print]

  • Chakraborti S, Mandal A, Das S, Chakraborti T (2005) Role of MMP-2 in PKCδ-mediated inhibition of Na+ dependent Ca2+ uptake in microsomes of pulmonary smooth muscle: involvement of a pertussis toxin sensitive protein. Mol Cell Biochem 280:107–117

    Article  PubMed  CAS  Google Scholar 

  • Chou WH, Messing RO (2008) Hypertensive encephalopathy and the blood-brain barrier: is δPKC a gatekeeper? J Clin Invest 118:17–20

    Article  PubMed  CAS  Google Scholar 

  • Clark WM, Lessov N, Lauten JD, Hazel K (1997) Doxycycline treatment reduces ischemic brain damage in transient middle cerebral artery occlusion in the rat. J Mol Neurosci 9:103–108

    Article  PubMed  CAS  Google Scholar 

  • Collino M, Aragno M, Mastrocola R, Gallicchio M, Rosa AC, Dianzani C, Danni O, Thiemermann C, Fantozzi R (2006) Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol 530:70–80

    Article  PubMed  CAS  Google Scholar 

  • Elkind MS (2009) Outcomes after stroke: risk of recurrent ischemic stroke and other events. Am J Med 122:S7–S13

    Article  PubMed  Google Scholar 

  • Fainaru O, Adini I, Benny O, Bazinet L, Pravda E, D'Amato R, Folkman J (2008) Doxycycline induces membrane expression of VEcadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J 22:3728–3735

    Article  PubMed  CAS  Google Scholar 

  • Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston LL Jr, del Zoppo GJ (2004) Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35:998–1004

    Article  PubMed  CAS  Google Scholar 

  • Jiao H, Wang Z, Liu Y, Xue Y (2011) Specific role of tight junction protein claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J Mol Neurosci 44:130–139

    Article  PubMed  CAS  Google Scholar 

  • Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, Song YS, Niizuma K, Katsu M, Okami N, Yoshioka H, Sakata H, Goeders CE, Chan PH (2010) Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 41:172–179

    Article  PubMed  CAS  Google Scholar 

  • Kago T, Takagi N, Date I, Takenaga Y, Takagi K, Takeo S (2006) Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem Biophys Res Commun 339:1197–1203

    Article  PubMed  CAS  Google Scholar 

  • Koistinaho M, Malm TM, Kettunen MI, Goldsteins G, Starckx S, Kauppinen RA, Opdenakker G, Koistinaho J (2005) Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J Cereb Blood Flow Metab 25:460–467

    Article  PubMed  CAS  Google Scholar 

  • Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S (2004) Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 56:468–477

    Article  PubMed  Google Scholar 

  • Lin CW, Hou WC, Shen SC, Juan SH, Ko CH, Wang LM, Chen YC (2008) Quercetin inhibition of tumor invasion via suppressing PKCδ/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 29:1807–1815

    Article  PubMed  CAS  Google Scholar 

  • Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91

    Article  PubMed  CAS  Google Scholar 

  • Miettinen S, Roivainen R, Keinänen R, Hökfelt T, Koistinaho J (1996) Specific induction of protein kinase C delta subspecies after transient middle cerebral artery occlusion in the rat brain: inhibition by MK-801. J Neurosci 16:6236–6245

    PubMed  CAS  Google Scholar 

  • Porter KE, Thompson MM, Loftus IM, McDermott E, Jones L, Crowther M, Bell PR, London NJ (1999) Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis. Eur J Vasc Endovasc Surg 17:404–412

    Article  PubMed  CAS  Google Scholar 

  • Roach DM, Fitridge RA, Laws PE, Millard SH, Varelias A, Cowled PA (2002) Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg 23:260–269

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg GA, Navratil M, Barone F, Feuerstein G (1996) Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16:360–366

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29:2189–2195

    Article  PubMed  CAS  Google Scholar 

  • Shimakura A, Kamanaka Y, Ikeda Y, Kondo K, Suzuki Y, Umemura K (2000) Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion. Brain Res 858:55–60

    Article  PubMed  CAS  Google Scholar 

  • Smith JR, Gabler WL (1995) Protective effects of doxycycline in mesenteric ischemia and reperfusion. Res Commun Mol Pathol Pharmacol 88:303–315

    PubMed  CAS  Google Scholar 

  • Strbian D, Karjalainen-Lindsberg ML, Kovanen PT, Tatlisumak T, Lindsberg PJ (2007) Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation 116:411–418

    Article  PubMed  CAS  Google Scholar 

  • Tsukita S, Furuse M (1998) Overcoming barriers in the study of tight junction function: from occludin to claudin. Genes Cells 3:569–573

    Article  PubMed  CAS  Google Scholar 

  • Wang ZH, Xue YX, Liu YH (2010) The modulation of protein kinase A and heat shock protein 70 is involved in the reversible increase of blood-brain tumor barrier permeability induced by papaverine. Brain Res Bull 83:367–373

    Article  PubMed  CAS  Google Scholar 

  • Yang GY, Betz AL (1994) Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 25:1658–1665

    Article  PubMed  CAS  Google Scholar 

  • Yi JH, Park SW, Kapadia R, Vemuganti R (2007) Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem Int 50:1014–1027

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China (Nos. 30872656, 30973079, 81172197, 81171131, and 81072056), the special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities (Nos. 20092104110015 and 20102104110009), and Shenyang Science and Technology Plan Projects (Nos. F10-205-1-22 and F10-205-1-37).

Conflict of Interest Statement

The authors declare that they have no competing financial interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yixue Xue.

Additional information

Zhenhua Wang, Yixue Xue, and Haixia Jiao contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Z., Xue, Y., Jiao, H. et al. Doxycycline-Mediated Protective Effect Against Focal Cerebral Ischemia–Reperfusion Injury Through the Modulation of Tight Junctions and PKCδ Signaling in Rats. J Mol Neurosci 47, 89–100 (2012). https://doi.org/10.1007/s12031-011-9689-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-011-9689-x

Keywords

Navigation